18 January 2019
Sistema PJSFC, a publicly traded diversified Russian holding company, has acquired an equity interest in JSC Pharmaceutical Enterprise Obolenskoe (OBL Pharm), a leading Russian pharmaceutical company. The stake was acquired jointly with VTB Bank and members of the OBL Pharm management team. The investment consortium collectively acquired 95.14% of OBL Pharm for a total investment of RUB15.5 billion. The transaction represents a milestone in the creation of a major Russian pharmaceuticals group.
Latham & Watkins advised Sistema in the transaction with a Moscow team led by corporate partner Olga Ponomarenko with associates Timur Bayramov, Ivan Alaev, Vladimir Mikhailovsky, and Bairta Ochirova.